Manuscript accepted on : 10 March 2015
Published online on: --
Stem Cell-Based Therapy in Human Neurodegenerative Diseases
Esmaeel Ebrahimi1, Seyed Ahmad Hosseini2, Saeed Shirali3* and Mostafa Cheshmposh1
1Department of Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. 2Nutrition and Metabolic Diseases Research Center ,Ahvaz Jundishapur, University of Medical Sciences, Ahvaz, Iran. 3Hyperlipidemia Research Center, Department of Laboratory Sciences, Faculty of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
DOI : http://dx.doi.org/10.13005/bbra/1600
ABSTRACT: Cell therapy is a procedure in which replace healthy cells to unhealthy and damaged cells. Due to lack of suitable methods for treatment of neurological diseases, patients have problems enormous. The lack of neurotransmitters and neurotrophic factors are main causes of these diseases. During the past decade, a variety of cells such as embryonic stem cells, fetal-derived neuronal cells, and induced pluripotent stem cells (iPSCs) have been used for compensate neurological deficits and treatment of these disorders in a variety of animal models. Several studies have been conducted to produce nerve cells by different types of stem cells. Although researchs in this field has progressed, their use is somewhat limited due to ethical problems and possible formation of teratoma. In this paper, we reviewed methods used of stem cells for the treatment of neurological disorders.
KEYWORDS: Cell Therapy; Neurological Diseases; Embryonic Stem Cells; Ipscs; Teratoma
Download this article as:Copy the following to cite this article: Ebrahimi E, Hosseini S. A, Shirali S, Cheshmposh M. Stem Cell-Based Therapy in Human Neurodegenerative Diseases. Biosci Biotech Res Asia 2015;12(spl.edn.1) |
Copy the following to cite this URL: Ebrahimi E, Hosseini S. A, Shirali S, Cheshmposh M. Stem Cell-Based Therapy in Human Neurodegenerative Diseases. Biosci Biotech Res Asia 2015;12(spl.edn.1). Biosci Biotech Res Asia 2015;12(spl.edn.1). Available from:https://www.biotech-asia.org/?p=12539 |
This work is licensed under a Creative Commons Attribution 4.0 International License.